Highlights
ASX: PGL       PROSPA GROUP LIMITED.
Last Price Today's Change   Day's Range   Trading Volume
1.90   +0.045 (2.43%)  1.875 - 1.92  102,879

Overview

 
Avg Volume (4 weeks):515,161
4 Weeks Range:1.855 - 3.98
4 Weeks Price Volatility (%):
2.12%
52 Weeks Range:1.855 - 5.09
52 Weeks Price Volatility (%):
1.39%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Progen Pharmaceuticals Limited operates in the biotechnology industry. The Company's activities include the discovery, research and development of pharmaceutical therapeutics for the treatment of human diseases, and the provision of contract services related to the process development, manufacture and quality assurance of biopharmaceutical products. Its operating segments include Research & Development, and Manufacturing. It focuses on the development of the anti-angiogenesis and anti-metastatic oncology products pipeline. PI-88 and PG545 are anti-cancer agents with a dual mechanism of action critical to the growth of solid tumors and progression, namely angiogenesis and metastasis. The compounds also block signaling of multiple growth factors, such as FGF-1, FGF-2 and vascular endothelial growth factor (VEFG). The Company's technology works to disrupt tumors growth by preventing the process by which angiogenic growth factor proteins trigger blood vessel growth.

  Be the first to like this.
 


 

596  537  824  2385 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 WRM 0.005+0.001 
 IMU 0.036-0.003 
 FTT 0.0030.00 
 TLS 3.69+0.04 
 E2E 0.0050.00 
 HSC 0.007+0.001 
 CTM 0.011-0.001 
 NHL 0.054+0.004 
 ANW 0.002+0.001 
 SEA 0.1650.00 
Partners & Brokers